Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,544.2
-1.4 (-0.05%)

 

  • STI Straits Times Index
    2,544.2
    -1.4 (-0.05%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,564.7
    -6.9 (-0.44%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,890.7
    513.2 (2.11%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,340.3
    -39.0 (-1.15%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,750.2
    420.3 (1.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,190.2
    32.3 (0.63%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,407.6M
  • Value: 1,739.9M
  • Rise: 157
  • Fall: 186
  • Unch: 465

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008-
Jiutian Chemical0.019+0.002
ThaiBev0.605-
ISDN0.400+0.005
Genting Sing0.675-0.005
Intl Cement0.048+0.023
Polaris0.003-
China Real Estate0.002-
Keppel Corp4.800-0.600
Singtel2.360-0.020

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

TBG DIAGNOSTICS LTD TBG DIAGNOSTICS LTD
Updated on 11 Aug 2020 (End of trading day)
Last (AUD): 0.270 Change: - High: 0.270 Remarks: -
Change (%): - Low: 0.270
Open 0.270 Yesterday's Close 0.27
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) - Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.02753 Trailing EPS (AUD) e -0.02753 NAV (AUD) b 0.0591
PE a - Trailing PE f - Price / NAV b 4.5685
Dividend (AUD) d - Cash In Hand (AUD) g 0.0239 Issued & Paid-up Shares c 217,587,000
Dividend Yield (%) d - Price / Cash In Hand g 11.297 Treasury Shares h -
Beta - 75 Daysi 0.322 R-Squared - 75 Days(%)i 0.03 Market Cap (M) 58.748
Beta - 500 Daysi 0.020 R-Squared - 500 Days (%)i - Enterprise Value (M) 54.686
Piotroski F Score 3 Exchange Code TDL Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 261.67 Free Float (%) -
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 May 2016.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 09 Mar 2016.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference TBG DIAGNOSTICS LTD ASX 58.748 - - 4.5685 -
Industry Pharmaceuticals: Major ASX 99.128 - - 8.2961 -
Local Peer AFT PHARMACEUTICALS LTD ASX 444.418 39.981 39.983 26.5957 -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 394.917 - - 10.3718 -
Local Peer PYC THERAPEUTICS LIMITED ASX 366.447 - - 11.4679 -
Local Peer RECCE PHARMACEUTICALS LTD ASX 194.628 - - 41.2844 -
Local Peer RACE ONCOLOGY LTD ASX 105.581 - - 19.3258 -
Local Peer PALLA PHARMA LTD ASX 106.426 - - 1.4903 -
Local Peer ONCOSIL MEDICAL LIMITED ASX 87.003 - - 11.9318 -
Local Peer IMMURON LIMITED ASX 82.917 - - 12.0915 -
Local Peer NOXOPHARM LTD ASX 72.488 - - -20.0000 -
Local Peer INVION LTD ASX 52.256 - - 10.5556 -
Local Peer PHARMAXIS ASX 41.501 - - 29.1667 -
Local Peer MEDLAB CLINICAL LIMITED ASX 40.553 - - 3.2009 -
Other Local Peers ACRUX (ASX), EXOPHARM LTD (ASX), TALI DIGITAL LIMITED (ASX), CELLMID LIMITED (ASX), SUDA PHARMACEUTICALS LTD (ASX), CRESO PHARMA LTD (ASX), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX)
Global Peer JOHNSON & JOHNSON NYSE 389,736.345 25.778 25.666 6.1884 2.533
Global Peer PFIZER INC NYSE 213,328.623 13.110 15.049 3.3159 3.787
Global Peer MERCK & CO INC NYSE 204,640.808 20.791 19.529 7.4032 2.804
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 203,261.073 28.839 28.160 3.7773 2.236
Global Peer ABBVIE INC NYSE 163,034.995 20.790 23.621 11.0848 3.982
Global Peer ELI LILLY AND COMPANY NYSE 146,339.910 31.553 26.048 35.7543 1.688
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 145,348.133 108.427 67.519 11.8777 2.474
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 139,337.953 40.517 - 2.8382 2.686
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 128,184.762 39.397 10.436 1.8029 2.296
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 117,127.627 20.059 25.660 - 1.760
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), ROYALTY PHARMA PLC (NASDAQ), HANSOH PHARMA (HKEx), CANSINOBIO-B (HKEx), INNOVENT BIO (HKEx), REPLIGEN CORP (NASDAQ), SINOPHARM (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), ALLAKOS INC (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), HENLIUS-B (HKEx), NEKTAR THERAPEUTICS (NASDAQ), CHINAGRANDPHARM (HKEx), CHINARES PHARMA (HKEx), OPKO HEALTH INC (NASDAQ), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ADC THERAPEUTICS SA (NYSE), REATA PHARMACEUTICALS INC (NASDAQ), HEPALINK (HKEx), HYGEIA HEALTH (HKEx), CMS (HKEx), AKESO-B (HKEx), PRINCIPIA BIOPHARMA INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), OCUMENSION-B (HKEx), TRAD CHI MED (HKEx), INNOCARE-B (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), UNITED LAB (HKEx), SSY GROUP (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), CSTONE PHARMA-B (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZYMEWORKS INC (NYSE), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Kimia Farma Tbk. (IDX), KINIKSA PHARMACEUTICALS LTD (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), AMNEAL PHARMACEUTICALS INC (NYSE), AKERO THERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), CKLIFE SCIENCES (HKEx), PHATHOM PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), GOSSAMER BIO INC (NASDAQ), TONGRENTANGCM (HKEx), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), HUA MEDICINE-B (HKEx), PETIQ INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ANNEXON INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), IMMUNOTECH-B (HKEx), KEROS THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), TRICIDA INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), CRINETICS PHARMACEUTICALS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), IGBB (Bursa), INOZYME PHARMA INC (NASDAQ), 89BIO INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SHINEWAY PHARM (HKEx), KALA PHARMACEUTICALS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), AC IMMUNE SA (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), IMMUNIC INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), TOT BIOPHARM-B (HKEx), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMARA INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), FUSEN PHARM (HKEx), IDEAYA BIOSCIENCES INC (NASDAQ), BEYONDSPRING INC (NASDAQ), BSTEAD (Bursa), SUTRO BIOPHARMA INC (NASDAQ), PHARMA (Bursa), HOOKIPA PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), LANNETT CO INC (NYSE), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), POLYPID LTD (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), CH BIOTECH SER (HKEx), LOGICBIO THERAPEUTICS INC (NASDAQ), ZHONGZHIPHARM (HKEx), MUSTANG BIO INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), BIOMX INC (NYSE American), TFF PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), DAWNRAYS PHARMA (HKEx), CYCLERION THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), HARROW HEALTH INC (NASDAQ), GENPREX INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), ESSA PHARMA INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), IX Biopharma (SGX), CHECKPOINT THERAPEUTICS INC (NASDAQ), EVOLUS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), Hyphens Pharma (SGX), CORVUS PHARMACEUTICALS INC (NASDAQ), Phapros Tbk. (IDX), NOVAN INC (NASDAQ), KOTRA (Bursa), APTORUM GROUP LIMITED (NASDAQ), Merck Tbk. (IDX), MEDIWOUND LTD (NASDAQ), NEW RAY MEDIC (HKEx), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), NOVA (Bursa), TREVI THERAPEUTICS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), IP (SET), CLEARSIDE BIOMEDICAL INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), PAK FAH YEOW (HKEx), BIOHLDG (Bursa), EDESA BIOTECH INC (NASDAQ), EYENOVIA INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), NC HEALTHCARE (HKEx), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CHARMACY PHAR (HKEx), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), NEP INTERLONG (HKEx), BAUDAX BIO INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), MANNATECH INC (NASDAQ), WAI YUEN TONG (HKEx), HOTH THERAPEUTICS INC (NASDAQ), ANNOVIS BIO INC (NYSE American), SANAI HEALTH GP (HKEx), MILLENDO THERAPEUTICS INC (NASDAQ), JCT (SET), HISTOGEN INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), PURAPHARM (HKEx), ENTERA BIO LTD (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), EXTRAWELL PHAR (HKEx), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), SUNZEN (Bursa), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), PASHUN INT'L (HKEx), SINOLIFE UTD (HKEx), TELIGENT INC NEW (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), Merck Sharp Dohme Pharma Tbk. (IDX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months ---
6 Months -+0.238
+743.75 %
1 Year -+0.239
+770.97 %
Long Term Return 2 Years -+0.214
+382.14 %
3 Years -+0.135
+100.00 %
Annualised Return Annualised --
+25.99 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.018 - 0.300 Change From 1 Year Low +0.252 % Change From 1 Year Low (%) +1400.00
Change From 1 Year High -0.030 % Change From 1 Year High (%) -10.00
2 Years Range 0.018 - 0.300 Change From 2 Years Low +0.252 % Change From 2 Years Low (%) +1400.00
Change From 2 Years High -0.030 % Change From 2 Years High (%) -10.00
5 Years Range 0.018 - 0.300 Change From 5 Years Low +0.252 % Change From 5 Years Low (%) +1400.00
Change From 5 Years High -0.030 % Change From 5 Years High (%) -10.00
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
11 Aug 2020 0.270 0.270 0.270 0.270 - -
10 Aug 2020 0.270 0.270 0.270 0.270 - -
07 Aug 2020 0.270 0.270 0.270 0.270 - -
06 Aug 2020 0.270 0.270 0.270 0.270 - -
05 Aug 2020 0.270 0.270 0.270 0.270 - -
04 Aug 2020 0.270 0.270 0.270 0.270 - -
03 Aug 2020 0.270 0.270 0.270 0.270 - -
31 Jul 2020 0.270 0.270 0.270 0.270 - -
30 Jul 2020 0.270 0.270 0.270 0.270 - -
29 Jul 2020 0.270 0.270 0.270 0.270 - -
28 Jul 2020 0.270 0.270 0.270 0.270 - -
27 Jul 2020 0.270 0.270 0.270 0.270 - -
24 Jul 2020 0.270 0.270 0.270 0.270 - -
23 Jul 2020 0.270 0.270 0.270 0.270 - -
22 Jul 2020 0.270 0.270 0.270 0.270 - -
21 Jul 2020 0.270 0.270 0.270 0.270 - -
20 Jul 2020 0.270 0.270 0.270 0.270 - -
17 Jul 2020 0.270 0.270 0.270 0.270 - -
16 Jul 2020 0.270 0.270 0.270 0.270 - -
15 Jul 2020 0.270 0.270 0.270 0.270 - -
14 Jul 2020 0.270 0.270 0.270 0.270 - -
13 Jul 2020 0.270 0.270 0.270 0.270 - -
Summary
Current 2 Weeks
(29 Jul 2020 to 11 Aug 2020)
0.270 0.270 0.270 0.270 - -
Previous 2 Weeks
(15 Jul 2020 to 28 Jul 2020)
0.270 0.270 0.270 0.270 - -
4 Weeks from
(16 Jun 2020 to 14 Jul 2020)
0.270 0.270 0.270 0.270 - -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.